Trump administration affirms drug price talks

What’s Trump Done on Prescription Drug Prices So Far – and What Might Be Next?
An early move by the president has raised questions about what direction his second-term policy on drug costs will take.
Where $2 prescription drug prices, Obamacare stand in Trump executive order onslaught
Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 generic drugs for $2 a month, according to another executive order signed on Trump's first day in his new term.
Trump's administration aims for 'greater transparency' in drug price negotiations
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.
Medicare drug price negotiations need something new: a floor
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by introducing floors.
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more transparent.
US govt looks to bring 'greater transparency' in Medicare drug price negotiations
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug price negotiation program under President Donald Trump's administration. The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.
Maine bill aims to protect federal drug pricing program
Lawmakers unveiled the bill that requires pharmaceutical manufacturers to sell certain drugs to care centers and pharmacies in underserved areas at a discount.
CMS aiming for more transparency in drug pricing negotiations
The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation Reduction Act of 2022.
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
Cigna plans to limit out-of-pocket drug costs for U.S. patients
President Donald Trump in December said he wanted to “knock out the middleman” in drug purchasing.
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
The Economist1h
The bad side-effects of China’s campaign to cut drug costs
These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...
New Analysis Finds the Medicare Drug Price Negotiation Program Threatens Financial Stability of American Pharmacies
Today, the National Community Pharmacists Association released a first-of-its-kind analysis, Unpacking the Financial Impacts of Medicare Drug Price Negotiation, conducted by 3 Axis Advisors. The ...
Trump Order Didn’t Reverse All of Biden’s Measures to Lower Drug Costs
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
Legislators try again to create state board to review drug prices
For five years now, a bipartisan group of Illinois lawmakers have wanted to establish a Prescription Drug Affordability Board ...
Sen. Dick Durbin: Big Pharma should disclose prices on drug advertisements
Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...